Amgen Inc.
AMGNNASDAQHealthcare● Active
$345.73
$-3.85(-1.10%)
Market Cap$186.6B
P/E Ratio—
52W High$391.29
52W Low$267.83
Amgen Inc.（AMGN）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AMGN · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $7.71B | $4.09B | $6.72B | $6.55B | $5.89B |
| Depreciation & Amort. | $5.17B | $5.59B | $4.07B | $3.42B | $3.40B |
| Stock-Based Comp. | $0.00B | $0.53B | $0.43B | $0.40B | $0.34B |
| Change in Working Capital | ($1.98B) | $2.37B | ($0.48B) | ($0.73B) | ($1.19B) |
| Net Cash from Operations | $9.96B | $11.49B | $8.47B | $9.72B | $9.26B |
| Investing Activities | |||||
| Capital Expenditure | ($1.86B) | ($1.10B) | ($1.11B) | ($0.94B) | ($0.88B) |
| Purchases of Investments | $0.00B | $0.00B | ($0.00B) | ($2.59B) | ($8.90B) |
| Sales of Investments | $0.00B | $0.00B | $1.67B | $1.22B | $13.23B |
| Net Cash from Investing | ($1.94B) | ($1.05B) | ($26.20B) | ($6.04B) | $0.73B |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | ($0.20B) | $0.00B | ($6.36B) | ($4.97B) |
| Dividends Paid | ($5.12B) | ($4.83B) | ($4.56B) | ($4.20B) | ($4.01B) |
| Debt Issued / Repaid | ($5.68B) | ($4.26B) | $25.68B | $6.62B | $0.80B |
| Net Cash from Financing | ($10.86B) | ($9.41B) | $21.05B | ($4.04B) | ($8.27B) |
| Free Cash Flow | |||||
| Free Cash Flow | $8.10B | $10.39B | $7.36B | $8.79B | $8.38B |
| FCF Margin %(computed) | 22.05% | 31.10% | 26.11% | 33.37% | 32.26% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Amgen Inc.
关于Amgen Inc.（AMGN）现金流量表
Amgen Inc. 2025财年经营活动现金流$9.96B，自由现金流$8.10B（FCF利润率22.05%），资本支出($1.86B)。
常见问题
AMGN · 4 问Amgen Inc. 2025财年自由现金流$8.10B，同比down22.1%。
AMGN free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10